- 15:21, September 19, 2023 diff hist +1 m Sarcoid Uveitis current
- 15:21, September 19, 2023 diff hist +5 m Human T-cell Lymphotropic Virus Type 1 Uveitis current
- 15:20, September 19, 2023 diff hist +3 m Comprehensive Drop Guide current
- 15:20, September 19, 2023 diff hist +1 m Cyclosporine current
- 15:19, September 19, 2023 diff hist +1 m Tumor Necrosis Factor Blockers current
- 15:19, September 19, 2023 diff hist 0 m Immunomodulatory Therapy (IMT) for Ocular Inflammation current
- 15:18, September 19, 2023 diff hist +5 m Leprosy current
- 15:18, September 19, 2023 diff hist 0 m Scleromalacia Perforans current
- 15:17, September 19, 2023 diff hist +1 m Intermediate Uveitis current
- 15:16, September 19, 2023 diff hist +1 m Serpiginous Choroidopathy current
- 15:16, September 19, 2023 diff hist 0 m Synechiae current
- 15:15, September 19, 2023 diff hist 0 m Punctate Inner Choroidopathy current
- 15:12, September 19, 2023 diff hist +1 m Arlt's Triangle current
- 13:27, December 20, 2022 diff hist +4 m Cyclosporine
- 13:26, December 20, 2022 diff hist +4 m Serpiginous Choroidopathy
- 13:25, December 20, 2022 diff hist -3 m Tumor Necrosis Factor Blockers
- 13:24, December 20, 2022 diff hist 0 m Tumor Necrosis Factor Blockers
- 13:24, December 20, 2022 diff hist +4 m Tumor Necrosis Factor Blockers
- 13:22, December 20, 2022 diff hist 0 m Sarcoid Uveitis
- 13:21, December 20, 2022 diff hist +4 m Intermediate Uveitis
- 13:14, December 20, 2022 diff hist -5 m Fuchs Heterochromic Iridocyclitis
- 13:05, December 20, 2022 diff hist +4 m Arlt's Triangle
- 10:48, September 10, 2022 diff hist +5 m Synechiae
- 10:46, September 10, 2022 diff hist +5 m Immunomodulatory Therapy (IMT) for Ocular Inflammation
- 10:45, September 10, 2022 diff hist +5 m Scleromalacia Perforans
- 10:45, September 10, 2022 diff hist +5 m Punctate Inner Choroidopathy
- 00:19, June 17, 2022 diff hist +2 m Cyclosporine
- 00:18, June 17, 2022 diff hist +2 m Intermediate Uveitis
- 00:16, June 17, 2022 diff hist +2 m Arlt's Triangle
- 00:16, June 17, 2022 diff hist +2 m Tumor Necrosis Factor Blockers
- 00:15, June 17, 2022 diff hist +2 m Serpiginous Choroidopathy
- 12:14, March 8, 2022 diff hist -4 m Human T-cell Lymphotropic Virus Type 1 Uveitis
- 12:13, March 8, 2022 diff hist -4 m Leprosy
- 12:11, March 8, 2022 diff hist -4 m Scleromalacia Perforans
- 12:10, March 8, 2022 diff hist -1 m Punctate Inner Choroidopathy
- 12:09, March 8, 2022 diff hist -4 m Immunomodulatory Therapy (IMT) for Ocular Inflammation
- 12:07, March 8, 2022 diff hist -1 Synechiae
- 00:36, December 8, 2021 diff hist 0 m Serpiginous Choroidopathy
- 00:35, December 8, 2021 diff hist -1 m Tumor Necrosis Factor Blockers
- 00:35, December 8, 2021 diff hist -1 m Intermediate Uveitis
- 00:34, December 8, 2021 diff hist 0 Cyclosporine
- 00:33, December 8, 2021 diff hist -1 m Fuchs Heterochromic Iridocyclitis
- 00:33, December 8, 2021 diff hist 0 m Arlt's Triangle
- 23:09, September 7, 2021 diff hist 0 m Coccidioidomycosis (Valley Fever)
- 23:07, September 7, 2021 diff hist 0 m Human T-cell Lymphotropic Virus Type 1 Uveitis
- 19:36, September 3, 2021 diff hist +1 m Ebola Virus
- 19:22, September 3, 2021 diff hist +1 m Immunomodulatory Therapy (IMT) for Ocular Inflammation
- 19:21, September 3, 2021 diff hist +8 m Immunomodulatory Therapy (IMT) for Ocular Inflammation →Side effects of steroid
- 19:20, September 3, 2021 diff hist +12 m Immunomodulatory Therapy (IMT) for Ocular Inflammation →Expected onset of anti-inflammatory action Tag: Visual edit
- 19:19, September 3, 2021 diff hist 0 m Immunomodulatory Therapy (IMT) for Ocular Inflammation →Baseline tests and follow-up tests for IMT